40
Participants
Start Date
March 26, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2028
No Intervention: Observational Cohort
The patients with R/M SGC would receive drug treatment according to the clinical guideline or doctor's experience, at the same time, tumor biopsy samples would be collected to establish PDO for drug sensitive test. But no intervention would be used based on the PDO drug sensitive test.
ACTIVE_NOT_RECRUITING
Huashan Hospital, Fudan University, Shanghai
RECRUITING
Huashan Hospital, Fudan University, Shanghai
Shanghai Cancer Hospital, China
OTHER
Eye & ENT Hospital of Fudan University
OTHER
Dongfang Hospital Affiliated to Tongji University
OTHER
Shandong Cancer Hospital and Institute
OTHER
Qilu Hospital of Shandong University
OTHER
Shandong Provincial Hospital
OTHER_GOV
Hospital of Stomatology, Wuhan University
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Zhejiang University
OTHER
Sir Run Run Shaw Hospital
OTHER
Zhejiang Cancer Hospital
OTHER
Shanghai Huangpu District Central Hospital
UNKNOWN
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Wuhan TongJi Hospital
OTHER
Zhongnan Hospital
OTHER
Huashan Hospital
OTHER